Reduction of cerebral infarct size by the AT₁-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination An experimental study in ratsENGELHORN, Tobias; DOERFLER, Arnd; HEUSCH, Gerd et al.Neuroscience letters. 2006, Vol 406, Num 1-2, pp 92-96, issn 0304-3940, 5 p.Article

AT₁ receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressureVARAGIC, Jasmina; FROHLICH, Edward D; SUSIE, Dinko et al.American journal of physiology. Heart and circulatory physiology. 2008, Vol 63, Num 2, issn 0363-6135, H853-H858Article

Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT₁-receptor blocker over thiazide alone on renoprotection in L-NAME/SHRXIAOYAN ZHOU; MATAVELLI, Luis C; ONO, Hidehiko et al.American journal of physiology. Renal physiology. 2005, Vol 58, Num 4, pp F871-F879, issn 1931-857XArticle

The importance of early antihypertensive efficacy : the role of angiotensin II receptor blocker therapyBASILE, J. N; CHRYSANT, S.Journal of human hypertension. 2006, Vol 20, Num 3, pp 169-175, issn 0950-9240, 7 p.Article

Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffnessANDREADIS, E. A; SFAKIANAKIS, M. E; DIAMANTOPOULOS, E. J et al.International angiology. 2010, Vol 29, Num 3, pp 266-272, issn 0392-9590, 7 p.Article

Evaluation of intrarenal hemodynamics by Doppler ultrasonography for renoprotective effect of angiotensin receptor blockadeOGATA, C; KAMIDE, K; SUZUKI, Y et al.Clinical nephrology. 2005, Vol 64, Num 5, pp 352-357, issn 0301-0430, 6 p.Article

Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertensionMAITLAND, Karlene; BRIDGES, Lakeesha; DAVIS, Wendell P et al.Circulation (New York, N.Y.). 2006, Vol 114, Num 9, pp 905-911, issn 0009-7322, 7 p.Article

Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresisFUKUDA, Michio; YAMANAKA, Tamaki; MIZUNO, Masashi et al.Journal of hypertension. 2008, Vol 26, Num 3, pp 583-588, issn 0263-6352, 6 p.Article

Regulation of angiotensin II receptors beyond the classical pathwayHORIUCHI, Masatsugu; IWANAMI, Jun; MOGI, Masaki et al.Clinical science (1979). 2012, Vol 123, Num 3-4, pp 193-203, issn 0143-5221, 11 p.Article

A Systematic Review of Angiotensin Receptor Blockers in Preventing StrokeLU, Guo-Cai; CHENG, Jin-Wei; ZHU, Ke-Ming et al.Stroke (1970). 2009, Vol 40, Num 12, pp 3876-3878, issn 0039-2499, 3 p.Article

Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantationMORATH, C; SCHMIED, B; DOEHLER, B et al.Clinical transplantation. 2009, Vol 23, pp 33-36, issn 0902-0063, 4 p., SUP21Conference Paper

Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantationGROENEWEGEN, Hendrik C; VAN DER HARST, Pim; ROKS, Anton J. M et al.International journal of cardiology. 2008, Vol 126, Num 2, pp 209-215, issn 0167-5273, 7 p.Article

Telmisartan Inhibits CD4-Positive Lymphocyte Migration Independent of the Angiotensin Type 1 Receptor via Peroxisome Proliferator-Activated Receptor-γWALCHER, Daniel; HESS, Katharina; MARX, Nikolaus et al.Hypertension (Dallas, Tex. 1979). 2008, Vol 51, Num 2, pp 259-266, issn 0194-911X, 8 p.Article

Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injurySHAO, Jing; NANGAKU, Masaomi; MIYATA, Toshio et al.Hypertension (Dallas, Tex. 1979). 2003, Vol 42, Num 1, pp 31-38, issn 0194-911X, 8 p.Article

Angiotensin II AT₁ receptor blockers as treatments for inflammatory brain disordersSAAVEDRA, Juan M.Clinical science (1979). 2012, Vol 123, Num 9-10, pp 567-590, issn 0143-5221, 24 p.Article

Angiotensin-(1-7) : Pharmacological properties and pharmacotherapeutic perspectivesIUSUF, Dilek; HENNING, Robert H; VAN GILST, Wiek H et al.European journal of pharmacology. 2008, Vol 585, Num 2-3, pp 303-312, issn 0014-2999, 10 p.Article

Emerging Concepts of Regulation of Angiotensin II Receptors : New Players and Targets for Traditional ReceptorsMOGI, Masaki; IWAI, Masaru; HORIUCHI, Masatsugu et al.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 12, pp 2532-2539, issn 1079-5642, 8 p.Article

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysisGANG HUANG; XU, Jun-Bo; LIU, Xiao-Rong et al.European journal of clinical investigation. 2011, Vol 41, Num 7, pp 719-733, issn 0014-2972, 15 p.Article

Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. CommentaryWAEBER, Bernard; BURNIER, Michel; BURKE, Thomas A et al.Journal of hypertension. 2006, Vol 24, Num 6, issn 0263-6352, 1021-1022,1193-1200 [10 p.]Article

Effects of angiotensin II type 1-receptor blockade on retinal endothelial functionOTT, Christian; SCHLAICH, Markus P; HARAZNY, Joanna et al.Journal of hypertension. 2008, Vol 26, Num 3, pp 516-522, issn 0263-6352, 7 p.Article

Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin―angiotensin systemDE LA SIERRA, A.Journal of human hypertension. 2009, Vol 23, Num 8, pp 503-511, issn 0950-9240, 9 p.Article

Effects of anti-hypertensive treatment on graft function and proteinuria in a kidney transplant from an elderly hypertensive donorKOBAYASHI, Akimitsu; YAMAMOTO, Hiroyasu; MIYAZAKI, Yoichi et al.Clinical transplantation. 2008, Vol 22, pp 68-71, issn 0902-0063, 4 p., SUP19Conference Paper

Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-γ-modulating activity, on nitric oxide bioavailability and atherosclerotic changeIKEJIMA, Hideyuki; IMANISHI, Toshio; AKASAKA, Takashi et al.Journal of hypertension. 2008, Vol 26, Num 5, pp 964-972, issn 0263-6352, 9 p.Article

Renin-Angiotensin System Associated with Risk of Upper GI Mucosal Injury Induced by Low Dose Aspirin: Renin Angiotensin System Genes' PolymorphismSHIOTANI, Akiko; NISHI, Ryuji; YAMANAKA, Yoshiyuki et al.Digestive diseases and sciences. 2011, Vol 56, Num 2, pp 465-471, issn 0163-2116, 7 p.Article

Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out miceRUI YAO; XIANG CHENG; YONG CHEN et al.International journal of cardiology. 2010, Vol 139, Num 2, pp 113-122, issn 0167-5273, 10 p.Article